JANE STREET GROUP, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$8,884,000
+369.1%
257,855
+127.5%
0.01%
+400.0%
Q2 2020$1,894,000
+367.7%
113,365
+303.4%
0.00%
Q1 2020$405,000
-68.8%
28,100
-27.5%
0.00%
-100.0%
Q4 2019$1,299,000
+464.8%
38,783
+253.6%
0.00%
Q3 2019$230,000
-55.8%
10,967
-42.5%
0.00%
-100.0%
Q3 2018$520,000
+145.3%
19,072
+141.4%
0.00%
Q2 2018$212,000
-60.2%
7,900
-52.8%
0.00%
-100.0%
Q1 2018$533,000
+111.5%
16,741
+68.4%
0.00%
-50.0%
Q3 2015$252,0009,9430.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders